Stemedica Cell Technologies, Inc.

Quick facts

Phase 1 pipeline

• Allogeneic Mesenchymal Bone Marrow Cells
  Mesenchymal stem cells modulate immune responses and secrete factors that may promote tissue regeneration and reduce inflammation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Stemedica Cell Technologies, Inc. portfolio CI brief
• Stemedica Cell Technologies, Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies